Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-05-31 · accession 0000950170-24-072493 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | 2024-05-31 | BMEA | Frias Juan Pablo | Chief Medical Off | A - Grant | $8.94 | +349 | 349 | New | +$3,120 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | A | A | 349 | $8.94 | 349 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on May 31, 2024. |